awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42011012-5F653C4F-E545-415D-BC8C-5BDD6C0FC6EC
Q42011012-5F653C4F-E545-415D-BC8C-5BDD6C0FC6EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42011012-5F653C4F-E545-415D-BC8C-5BDD6C0FC6EC
Syk inhibitors in clinical development for hematological malignancies.
P2860
Q42011012-5F653C4F-E545-415D-BC8C-5BDD6C0FC6EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42011012-5F653C4F-E545-415D-BC8C-5BDD6C0FC6EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51559c8dd40dc22e37eaf39a3f37d210f685469a
P2860
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.